GSA Capital Partners’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,063
Closed -$29K 1617
2023
Q4
$29K Buy
+1,063
New +$64.8K ﹤0.01% 1432
2023
Q2
Sell
-4,887
Closed -$311K 1532
2023
Q1
$311K Buy
4,887
+4,224
+637% +$482K 0.03% 1006
2022
Q4
$92K Sell
663
-6,916
-91% -$974K 0.01% 1317
2022
Q3
$959K Buy
+7,579
New +$857K 0.13% 178
2022
Q2
Sell
-988
Closed -$96K 1411
2022
Q1
$96K Buy
+988
New +$130K 0.01% 1299
2021
Q3
Sell
-941
Closed -$390K 1434
2021
Q2
$390K Sell
941
-6,007
-86% -$2.38M 0.04% 785
2021
Q1
$2.71M Buy
+6,948
New +$3.42M 0.45% 25
2020
Q2
Sell
-498
Closed -$296K 654
2020
Q1
$296K Buy
+498
New +$485K 0.07% 497
2018
Q2
Sell
-1,576
Closed -$3.48M 1683
2018
Q1
$3.48M Buy
+1,576
New +$4.01M 0.18% 73
2016
Q4
Sell
-265
Closed -$233K 1750
2016
Q3
$233K Buy
+265
New +$192K 0.01% 1521
2015
Q4
Sell
-4,509
Closed -$5M 1813
2015
Q3
$5M Buy
4,509
+1,893
+72% +$3.45M 0.25% 45
2015
Q2
$5.7M Buy
2,616
+1,805
+223% +$3.68M 0.22% 43
2015
Q1
$1.27M Sell
811
-772
-49% -$1.02M 0.05% 676
2014
Q4
$1.88M Buy
1,583
+564
+55% +$377K 0.13% 167
2014
Q3
$474K Buy
+1,019
New +$470K 0.02% 963

Other funds holding BLUE

GSA Capital Partners's BLUE Position: Q1 2024 in Review

GSA Capital Partners sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 1,063 shares — an estimated $29K sold.

GSA Capital Partners first reported a position in BLUE in Q3 2014 and held it in 15 quarters. The position peaked at $5.7M in Q2 2015. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • GSA Capital Partners reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • GSA Capital Partners sold 1,063 bluebird bio shares in Q1 2024, an estimated $29K.
  • GSA Capital Partners first reported a position in bluebird bio in Q3 2014 and held it in 15 quarters.
  • GSA Capital Partners's bluebird bio position peaked at $5.7M in Q2 2015.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on GSA Capital Partners's 13F filing for Q1 2024, filed 3 May 2024.